STERIS STE Ratios & Valuation
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 176.8%+3.0pp | 173.7%-0.3pp | 174%-4.1pp | 178.1%+5.2pp | |
| Operating margin | 69.4%+5.7pp | 63.7%-25.2pp | 88.9%+49.6pp | 39.3%-6.5pp | |
| Net margin | 49%+13.3pp | 35.7%+3.0pp | 32.7%+23.0pp | 9.6%-17.1pp | |
| Returns | |||||
| Return on equity | 41.6%+11.6pp | 30%+3.7pp | 26.3%+19.4pp | 6.9%-13.7pp | |
| Return on invested capital | 34.9%+5.3pp | 29.5%-8.5pp | 38.1%+22.8pp | 15.2%-3.6pp | |
| Efficiency | |||||
| Asset turnover | 2.2×+0.2× | 2×+0.2× | 1.8×+0.2× | 1.6×-0.2× | |
| Liquidity | |||||
| Current ratio | 9.2×+0.3× | 8.8×-1.5× | 10.3×+1.3× | 9×+0.7× | |
| Leverage | |||||
| Debt-to-equity | 1.1×-0.3× | 1.5×-0.7× | 2.1×0.0× | 2.1×0.0× | |
| Net debt / EBITDA | 4.3×-2.1× | 6.4×-1.3× | 7.8×-4.0× | 11.8×-3.7× | |
| Valuation | |||||
| Market capitalization | $94.51B+7.1% | $88.24B+0.5% | $87.83B+17.7% | $74.63B-16.7% | |
| Price / earnings | 134.7×-54.3× | 189×-134× | 322.7×— | —— | |
| Price / sales | 16.4×-0.1× | 16.5×-1.4× | 17.9×+1.6× | 16.4×-6.0× | |
| Price / book | 13.4×-0.2× | 13.6×-0.4× | 14×+1.8× | 12.3×-1.4× | |
| EV / EBITDA | 68.1×-3.5× | 71.6×+9.2× | 62.3×-22.7× | 85.1×-39.5× | |
| Dividend yield | 4%+0.1pp | 3.9%+0.3pp | 3.5%-0.3pp | 3.8%+1.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are STERIS's profit margins?
- STERIS (STE) runs a 44.2% gross margin and a 18.6% operating margin, with a 13.2% net margin.
- Where do STERIS's ratios come from?
- Every ratio is computed from STERIS's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
